Delivery Order SPE2DB20D2104-SPE2DB25FMYRU
- Not listed
- The Defense Logistics Agency awarded a $2,280.80 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 8, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $4,124.80 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. This firm fixed price delivery order, effective through August 12, 2025, represents a competitively awarded, non-set-aside procurement issued on August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,546.80 to AmerisourceBergen Drug Corp for the supply of Dexcom G7 sensors. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 12, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price contract represents a non-competitive, non-set-aside award for continuous glucose monitoring devices to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,062.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. The contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive set-aside delivery order under a larger indefinite delivery contract (IDC) vehicle. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this medical device...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.40 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. This firm fixed-price delivery order, issued on August 11, 2025, with a completion date of August 12, 2025, represents a non-competitive set-aside award. The sensors will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the agency's medical supply chain operations for federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $4,871.27 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. This firm fixed-price, competitively awarded contract was finalized on August 14, 2025, with an ultimate completion date of August 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors valued at $2,188.74. This firm fixed-price delivery order was competitively awarded without a set-aside designation and carries an ultimate completion date of July 22, 2025. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dexcom G7 sensors, continuous glucose monitoring devices used in diabetes management. This competitively awarded, non-set-aside contract has a ceiling value of $2,165.52 and firm fixed pricing, with an ultimate completion date of August 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,474.88 to AmerisourceBergen Drug Corp for the supply of Dexcom G7 sensors. This firm fixed price, non-competitive delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial role as a federal medical supply provider,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYRUDelivery Order
The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors valued at $2,845.71. This firm fixed-price contract, executed on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The award was competitively solicited with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls within the scope of AmerisourceBergen's comprehensive prime vendor agreement to supply pharmaceutical products and medical devices to support military healthcare programs worldwide. The Dexcom G7 sensors represent specialized medical equipment for diabetes management, consistent with the contractor's extensive portfolio of therapeutic medications and medical supplies serving the Defense Health Agency and other federal healthcare systems. As a major pharmaceutical distributor serving the federal medical supply chain, AmerisourceBergen continues to fulfill critical healthcare commodities requirements across multiple therapeutic domains through its established DLA contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 8/22/25 |